ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

The 2019 ARP Awards of Distinction & ACR Masters

Carol Patton, with Keri Losavio  |  November 16, 2019

ATLANTA—At the 2019 ACR/ARP Annual Meeting in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find a…

Filed under:Awards Tagged with:2019 ACR/ARP Annual MeetingAnnelle ReedAssociation of Rheumatology Professionals (ARP)Dana GuglielmoDr. Calvin R. Brown Jr.Dr. Carlos PinedaDr. Chester V. OddisDr. Fredrica E. SmithDr. Gerd R. BurmesterDr. Geri NeubergerDr. Grant W. CannonDr. Hani El-GabalawyDr. J. Lee NelsonDr. James N. JarvisDr. John D. ReveilleDr. John J. O’SheaDr. Jonathan S. CoblynDr. Jürgen BraunDr. Lee Stuart SimonDr. Linda Kay MyersDr. Michelle A. PetriDr. Nighat Mir AhmadDr. Ronald M. LaxerDr. Rosalind Ramsey-GoldmanDr. Rowland W. ChangDr. Sharad LakhanpalDr. Simon HelfgottDr. William F.C. RigbyHeather BenhamJoni DeanMichael LaValleyMonique GignacRobert Richardson

Google Signs Healthcare Data & Cloud Computing Deal with Ascension

Reuters Staff  |  November 13, 2019

(Reuters)—Alphabet Inc.’s Google signed its biggest cloud computing customer in healthcare yet, according to an announcement on Monday, gaining with the deal datasets that could help it tune potentially lucrative artificial intelligence tools. The Wall Street Journal earlier reported Google teaming up with Ascension to collect personal health-related information of millions of Americans across 21…

Filed under:Information TechnologyTechnology Tagged with:AscensiondataGoogleHealth Information Technologypatient data

Insight into Achieving & Maintaining Target Serum Urate Levels in Gout Patients

Lara C. Pullen, PhD  |  November 11, 2019

A recent study advances the understanding of factors associated with a target serum urate level of 6 mg/dL or less. Researchers found such factors as having a rheumatologist as the main provider of gout care contributed to achieving and maintaining this outcome. However, the presence of co-morbidities lowered a patient’s chances for achieving the target serum urate level, even with allopurinol use…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:AllopurinolGoutserum urate levels

How to Walk on Water & Climb Up Walls: 2019 ACR/ARP Annual Meeting gets an inspirational kickoff in Atlanta

Keri Losavio  |  November 9, 2019

ATLANTA—Did you know that Tasmanian wombats have cube-shaped poop or that no matter what size bladder someone has, they still pee in 20–30 seconds—even elephants? What do those factoids have to do with rheumatology? When keynote speaker David L. Hu, PhD, shared the information and how he discovered it, the stories incited laughter in the…

Filed under:American College of RheumatologyMeeting Reports Tagged with:2019 ACR/ARP Annual Meeting

Ellen M. Gravallese, MD, Begins ACR Presidency

Susan Bernstein  |  November 7, 2019

As Ellen M. Gravallese, MD, begins the ACR presidency, her goals include workforce expansion, improved access to care and support for members in all areas of practice.

Filed under:American College of Rheumatology Tagged with:ACR presidentEllen Gravallese

Scottish Medicines Consortium Recommends Risankizumab; Plus Real-World Data on Secukinumab

Michele B. Kaufman, PharmD, BCGP  |  November 4, 2019

The Scottish Medicines Consortium has released a detailed advice document recommending risankizumab for treating adults with psoriasis…

Filed under:Drug Updates Tagged with:PsoriasisrisankizumabScottish Medicines Consortiumsecukinumab

Physical Activity Reduces Risk of Rheumatoid Arthritis

Lara C. Pullen, PhD  |  October 31, 2019

A recent study has taken a more detailed look at the relationship between physical activity and the risk of developing rheumatoid arthritis (RA). Researchers found the more patients exercised weekly the lower their overall risk, specifically brisk and very brisk walking paces, along with longer cumulative average walking hours weekly were associated with a reduced risk for RA…

Filed under:ConditionsRheumatoid Arthritis Tagged with:physical activityRheumatoid Arthritis (RA)walking

Do Patients with Ankylosing Spondylitis in Remission Still Need TNF Inhibitors?

Lara C. Pullen, PhD  |  October 24, 2019

Patients with axial spondyloarthritis have a chronic, immune-mediated inflammatory disease that tends to localize to the sacroiliac joints and spine. Ankylosing spondylitis is, perhaps, the most representative of this group of diseases. Rheumatologists treat patients with axial spondyloarthritis with biologics, such as tumor necrosis factor inhibitors (TNFi’s), which can improve quality of life, activity and…

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing SpondylitisRemissionTNF inhibitors

Nelosa/shutterstock.com

Men, Women & Medical Differences in Axial Spondyloarthropathy

Ruth Jessen Hickman, MD  |  October 24, 2019

Historically, ankylosing spondylitis was considered mainly a male disease. But it has become evident this predominance is not as great as previously believed. Here we discuss recent developments in the area, including potential differences between the sexes in symptom and disease burden, immunological and genetic background, diagnostic delay, treatment response and ongoing research questions. Medical…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing Spondylitisaxial spondyloarthritis (SpA)Gendersexual dimorphism

FDA Approves Rituximab for Children with GPA & MPA

Michele B. Kaufman, PharmD, BCGP  |  October 23, 2019

Intravenous rituximab can now be used to treat pediatric patients with GPA and MPA as young as two years old…

Filed under:Drug Updates Tagged with:giant cell arteritis (GCA)GPAmicroscopic polyangiitis (MPA)rituximabVasculitis

  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 330
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences